Back
Novo Nordisk A/S Vs. Biodexa Pharmaceuticals Plc Industry Stock Comparison
Sell
50
NVO
Novo Nordisk A/S
Last Price:
126.70
Seasonality Move:
1.51%
Sell
34
BDRX
Biodexa Pharmaceuticals Plc
Last Price:
0.74
Seasonality Move:
-10.98%
Sell
50
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
- The current Novo Nordisk A/S [NVO] share price is $127.86. The Score for NVO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Biodexa Pharmaceuticals Plc (BDRX)
is a Sell
Is Biodexa Pharmaceuticals Plc a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals Plc [BDRX] share price is $0.74. The Score for BDRX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $127.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals Plc's stock price today?
-
The Biodexa Pharmaceuticals Plc share price today is $0.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.47 | Sell |
Relative Strength Index (14 RSI): | 33.57 | Sell |
Chaikin Money Flow: | -888764 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
BDRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 38.94 | Sell |
Chaikin Money Flow: | -265263 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.79 - 0.97) | Sell |
Bollinger Bands (100): | (0.81 - 1.27) | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 132.97 | Sell |
20-day SMA: | 138.51 | Sell |
50-day SMA: | 138.47 | Sell |
200-day SMA: | 119.36 | Buy |
8-day EMA: | 132.95 | Sell |
20-day EMA: | 136.48 | Sell |
50-day EMA: | 136.51 | Sell |
200-day EMA: | 120.9 | Buy |
BDRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.82 | Sell |
20-day SMA: | 0.87 | Sell |
50-day SMA: | 0.99 | Sell |
200-day SMA: | 1.83 | Sell |
8-day EMA: | 0.81 | Sell |
20-day EMA: | 0.87 | Sell |
50-day EMA: | 0.96 | Sell |
200-day EMA: | 23.78 | Sell |
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $0.87 per share.
Biodexa Pharmaceuticals Plc Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.
Novo Nordisk A/S Technical Analysis
Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biodexa Pharmaceuticals Plc Technical Analysis
Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |